Sharps Compliance (NASDAQ:SMED) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Share on StockTwits

Sharps Compliance (NASDAQ:SMED) posted its quarterly earnings data on Wednesday. The industrial products company reported $0.03 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.02, Morningstar.com reports. The firm had revenue of $12.17 million for the quarter, compared to analysts’ expectations of $10.77 million. Sharps Compliance had a net margin of 0.48% and a return on equity of 0.83%.

Shares of NASDAQ:SMED opened at $3.90 on Friday. The stock has a market cap of $66.02 million, a PE ratio of 409.00, a PEG ratio of 1.45 and a beta of 0.24. The company’s fifty day moving average is $3.67 and its 200 day moving average is $3.58. Sharps Compliance has a 52 week low of $2.97 and a 52 week high of $4.47. The company has a quick ratio of 1.95, a current ratio of 2.49 and a debt-to-equity ratio of 0.04.

A number of equities analysts recently commented on the stock. Barrington Research reiterated a “buy” rating and issued a $4.50 target price on shares of Sharps Compliance in a research report on Tuesday, May 21st. TheStreet upgraded shares of Sharps Compliance from a “d+” rating to a “c-” rating in a research report on Wednesday. Roth Capital assumed coverage on shares of Sharps Compliance in a research report on Wednesday, July 24th. They issued a “buy” rating and a $4.50 target price on the stock. Zacks Investment Research cut shares of Sharps Compliance from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 25th. Finally, Robert W. Baird assumed coverage on shares of Sharps Compliance in a research report on Wednesday, July 24th. They issued a “buy” rating and a $4.50 target price on the stock. One investment analyst has rated the stock with a sell rating and three have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $4.38.

In other Sharps Compliance news, Director Parris H. Holmes, Jr. bought 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 13th. The shares were bought at an average price of $3.31 per share, for a total transaction of $132,400.00. Following the transaction, the director now directly owns 942,027 shares in the company, valued at $3,118,109.37. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In the last quarter, insiders purchased 46,250 shares of company stock worth $153,075. 20.70% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the stock. BlackRock Inc. grew its holdings in Sharps Compliance by 3.8% in the 2nd quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock worth $387,000 after acquiring an additional 4,013 shares during the last quarter. Lapides Asset Management LLC grew its holdings in Sharps Compliance by 13.3% in the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock worth $586,000 after acquiring an additional 19,300 shares during the last quarter. Morgan Stanley grew its holdings in Sharps Compliance by 34.3% in the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock worth $672,000 after acquiring an additional 48,199 shares during the last quarter. Wells Fargo & Company MN grew its holdings in Sharps Compliance by 8.3% in the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock worth $1,512,000 after acquiring an additional 32,600 shares during the last quarter. Finally, Quantum Capital Management grew its holdings in Sharps Compliance by 0.6% in the 1st quarter. Quantum Capital Management now owns 522,569 shares of the industrial products company’s stock worth $1,913,000 after acquiring an additional 3,223 shares during the last quarter. Institutional investors own 20.19% of the company’s stock.

Sharps Compliance Company Profile

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Read More: Does a trade war provide a risk to the global economy?

Earnings History for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.